About HeartSciences
HeartSciences is a company based in Austin (United States) founded in 2007. HeartSciences has raised $9.83 million across 11 funding rounds. The company has 15 employees as of April 30, 2024. HeartSciences offers products and services including MyoVista Insights and MyoVista wav ECG Device. HeartSciences operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Austin, United States
- Employees 15 as on 30 Apr, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Heartsciences Inc.
-
Annual Revenue
$4.35 K (USD)-76.61as on Apr 30, 2025
-
Net Profit
-$8.77 M (USD)-32.7as on Apr 30, 2025
-
EBITDA
-$8.22 M (USD)-32.43as on Apr 30, 2025
-
Total Equity Funding
$9.83 M (USD)
in 11 rounds
-
Latest Funding Round
$1.59 M (USD), Post-IPO
Nov 15, 2023
-
Investors
Not available
-
Employee Count
15
as on Apr 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HeartSciences
HeartSciences is a publicly listed company on the NASDAQ with ticker symbol HSCS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HeartSciences
HeartSciences offers a comprehensive portfolio of products and services, including MyoVista Insights and MyoVista wav ECG Device.
Cloud-based platform for AI-enhanced ECG analysis and diagnostics
Device integrating AI for improved electrocardiography testing
People of HeartSciences
Unlock access to complete
Funding Insights of HeartSciences
HeartSciences has successfully raised a total of $9.83M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.59 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by HeartSciences
Investment portfolio details for HeartSciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HeartSciences
Detailed financials for HeartSciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Heartsciences Comparisons
Peer comparison for HeartSciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HeartSciences
HeartSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Online health and wellness tracking and training platform
|
Detailed competitors of HeartSciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Heartsciences
Complete news archive for HeartSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeartSciences
HeartSciences was founded in 2007 and raised its 1st funding round 2 years after it was founded.
HeartSciences is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Mark Hilz is the current CEO of HeartSciences.
HeartSciences is a funded company, having raised a total of $9.83M across 11 funding rounds to date.
As of Apr 30, 2024, the latest employee count at HeartSciences is 15.
Annual revenue of HeartSciences is $4.35K as on Apr 30, 2025.
HeartSciences was founded in 2007 in Austin, United States, within the medical device sector. Operations center on cardiac screening technology, where Continuous Wavelet Transform signal processing is employed in the MyoVista device. Abnormalities in heart function are detected early through this approach. A visual mapping of the cardiac cycles energy distribution is delivered to physicians for assessment.
HeartSciences's top competitors include AliveCor, iRhythm Tech and Biotricity.
HeartSciences offers MyoVista Insights and MyoVista wav ECG Device.
Yes, HeartSciences is publicly traded on NASDAQ under the ticker symbol HSCS.
The ticker symbol of HeartSciences is HSCS on NASDAQ.